Common stock, par value $0.0001 per share
- Symbol
- ASBP
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 7.01, 9.01 · 8-K
Aspire-Lakewood Holdings, Inc.
ASBPNASDAQEQUITYCurrent
Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On August 19, 2026, the Company intends to distribute an investor presentation. A copy of the investor presentation is furnished hereto as Exhibit 99.1 and incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. Exhibit Description No.…
Company context
We are an early-stage biopharmaceutical and supplements company. On February 17, 2025, we completed a merger with Aspire Biopharma, Inc. (“Old Aspire”) and changed our name from Power Up Acquisition Corp. to Aspire Biopharma Holdings, Inc. and became a Delaware corporation. The Company engages in the business of developing and marketing the disruptive technology for novel sublingual delivery mechanisms initially for known drugs. Prior to our Business Combination we were a privately held company Puerto Rican corporation incorporated in September 2021.
Current securities
Registered securities in this filing
Aspire Biopharma Holdings, Inc. · 8-K · Filed 2026-08-19
Warrants, each exercisable for one share of common stock
- Symbol
- ASBPW
- Exchange
- NASDAQ
- Classification
- WARRANT
- Status
- Current
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure
On
August 19, 2026,
the Company intends to distribute an investor presentation. A copy of the investor presentation is furnished hereto as Exhibit 99.1 and incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
Exhibit Description
No.
─────────────────────────────────────────────────────────────────────────────────────
99.1 Investor Presentation dated August 19, 2026
104 Cover
Page Interactive Data File (embedded with the Inline XBRL document).
Filed exhibits (1)
EX-99.1
Open exhibit ↗